title: Paraoxonase Arg 192 allele is an independent risk factor for three-vessel stenosis of coronary artery disease.
abstract: The role of the paraoxonase (PON1) codon 192 polymorphism [glutamine (Q)/arginine (R)] in coronary artery disease (CAD) is controversial. The aim of the present study was to evaluate whether the PON1 gene polymorphism is an independent risk factor for severity of coronary artery disease in patients from west of Iran. The PON1-Arg-192 genotypes were detected by PCR-RFLP in 414 individuals undergoing their first coronary angiography. Patients were placed into one of two groups: CAD and control without CAD or diabetes. The frequency of PON1-Arg-192 allele was significantly higher in the CAD (23.4 vs. 16%, P = 0.032) than in the control group and there was a higher risk of developing CAD (OR = 1.6, P = 0.02). In addition, this difference remained significant after adjustment for without history of diabetes (OR = 1.47, P = 0.048), presence of normolipidemia and absence of history of blood pressure (OR = 1.4, P = 0.05). This result indicated PON1-Arg-192 allele is a risk factor of CAD also when correcting for conventional risk factors. We found a significant association between the PON1-Arg-192 genotype (QR + RR) and the extent of CAD in CAD patients and CAD subjects without diabetes, represented by the increased frequency of three-vessel disease with OR = 1.49, P = 0.046; χ2 = 3.82, P = 0.048 and OR = 1.46, P = 0.05; χ2 = 3.48, P = 0.051, respectively. The CAD patients carrying PON1-Arg-192 genotype (QR + RR) had lower plasma HDL-C level (P = 0.019) and higher plasma LDL-C(P = 0.01) and TG(P = 0.05). Our results indicated that PON1-Arg-192 allele can be important independent risk factor of CAD in a west population of Iran, with carriers of PON1-Arg-192 having an increased frequency of three-vessel disease and also having a distinct plasma lipids profile. Larger collaborative studies are needed to confirm these results.
authors.affiliation: Fertility and Infertility Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran. asadvaisiraygani@kums.ac.i
authors.forename: Asad
authors.initials: A
authors.lastname: Vaisi-Raygani
authors.forename: Hori
authors.initials: H
authors.lastname: Ghaneialvar
authors.forename: Zohreh
authors.initials: Z
authors.lastname: Rahimi
authors.forename: Haidar
authors.initials: H
authors.lastname: Tavilani
authors.forename: Tayebeh
authors.initials: T
authors.lastname: Pourmotabbed
authors.forename: Ebrahim
authors.initials: E
authors.lastname: Shakiba
authors.forename: Aliakbar
authors.initials: A
authors.lastname: Vaisi-Raygani
authors.forename: Amir
authors.initials: A
authors.lastname: Kiani
authors.forename: Mahdi
authors.initials: M
authors.lastname: Aminian
authors.forename: Reza
authors.initials: R
authors.lastname: Alibakhshi
authors.forename: Cynthia
authors.initials: C
authors.lastname: Bartels
mesh_terms: D000483:Alleles; D001120:Arginine / Q000235:genetics*; D043303:Aryldialkylphosphatase / Q000235:genetics*; D016022:Case-Control Studies; D003324:Coronary Artery Disease / Q000097:blood / Q000150:complications* / Q000201:enzymology / Q000235:genetics*; D023921:Coronary Stenosis / Q000097:blood / Q000150:complications* / Q000201:enzymology / Q000235:genetics*; D003710:Demography; D048909:Diabetes Complications / Q000150:complications; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D007492:Iran; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D012307:Risk Factors
chemical_list: D008055:Lipids; D001120:Arginine; D043303:Aryldialkylphosphatase; C468406:PON1 protein, human